We studied the effects ofage and gender on cardiovascular responses to l3-adrenergic stimulation with the use oftwodimensionalechocardiography in 16 young (aged20-31) and 20 older(aged60-75) (FS-u es ) relationships weresteeperin the young men (-0.87 ± 0.28, n = 8) comparedto the oldermen (-0.41 ± 0.13, n = 10), and in the young women (-0.55 ± 0.14, n = 8) compared to the older women (-0.38 ± 0.13 
S
EVERAL studies have shown a progressive decline in the (3-adrenergic-stimulated inotropic and chronotropic responses with advancing age (1) (2) (3) (4) (5) (6) (7) (8) (9) . Most studies in humans, however, have focused on the age-associated changes in heart rate (HR) or vasodilation (1) (2) (3) (6) (7) (8) (9) and reported that older individuals exhibit blunted chronotropic responses to (3-adrenergic stimulation (1, 3, 7) . Recently, Stratton and colleagues (7, 10) reported diminished left ventricular ejection fraction responses to isoproterenol and exercise in older men, confirming the earlier observations in the experimental animals. However, little is known whether gender can influence the age-related decline in cardiovascular (3-adrenergic responses in humans. Gender plays a role in the cardiovascular responses to exercise. The changes in cardiac function in response to acute dynamic exercise differ between men and women (11) (12) (13) . Furthermore, gender has been shown to affect cardiac adaptations to exercise training (13, 14) as well as chronic pressure overload (15, 16) . Therefore, it would be plausible to expect that gender may also influence the inotropic responses to (3-adrenergic stimulation because one of the mechanisms underlying cardiovascular changes induced by either acute dynamic exercise or endurance exercise training involves increased activation of myocardial (3-adrenoreceptors (17-19) . Accordingly, this study was performed to characterize the differences in the cardiovascular responses to (3-adrenergic stimulation in young and older men and women. We hypothesized that although the older adults would exhibit a blunted left ventricular contractile response to (3-adrenergic stimulation compared to young subjects, the magnitude of the age-associated decline in the (3-adrenergic-stimulated increase in contractile function should be different between women and men.
METHODS

Subjects
Sixteen young (20-31 years) and 20 older (60-75 years) adults participated in this study. There were 8 men and 8 women in the young group, and 10 men and 10 women in the older group. The ages of the older men and women were 64.7 ± 4.7 (mean ± SD) years and 64.8 ± 3.8 years, respectively; and the young men and women were 24.5 ± 3.1 years and 25.3 ± 3.4 years, respectively. The subjects' characteristics for each group are summarized in Table 1 . All participants were sedentary, and the older adults were screened for the presence of coronary risk factors and clinical coronary artery disease. All subjects were healthy, nonsmokers (> 10 years), normotensive (BP~140/90 mm Hg), and asymptomatic. They had a normal cardiac examination and were not taking cardiovascular medications. A few subjects were taking multivitamins. None of the older subjects had evidence of myocardial ischemia, confirmed by a thallium-201 exercise stress test. None of the older women was on hormone replacement therapy.All subjects signed an informed written consent, and the study protocol was approved by the Human Studies Committee of the Washington University School of Medicine. All procedures were performed in accordance with Washington University School of Medicine guidelines. Y0 2max, as previously described (21) . Y0 2max was defined as the mean of the two highest consecutive 30-second V0 2 measurements that met at least two of the following criteria: (i) attainment of a plateau ofV0 2 with increasing exercise intensity, (ii) the highest recorded heart rate (HR) within ± 10 bpm the age-predicted maximal HR, and (iii) a respiratory exchange ratio> 1.10.
Left Ventricular Size and Systolic Performance
Left ventricular (LV) size and systolic function were assessed with the use of two-dimensional (2-D) echocardiography including 2D-guided M-mode images with a 2.5-MHz transducer (Hewlett-Packard Model 2500). Images were obtained using the standard views according to the guidelines recommended by the American Society of Echocardiography (22) . The enddiastolic dimension (EDD) and end-systolic dimension (ESD) were measured using standard guidelines (22) . Left ventricular mass (LVmass) was estimated using standard equations (23) . Fractional shortening (FS) was calculated as FS = 100(EDD-ESD)/EDD. Left ventricular end-systolic wall stress (<reS> was estimated as described by Grossman and colleagues (24) : <res = Prl2h(1 +h/2r), where P is systolic blood pressure (SBP) expressed as g/cnr', r is end-systolic radius (ESD/2), and h is endsystolic posterior wall thickness. Left ventricular contractile performance was assessed using the FS-<r es relationship by plotting FS as a function of <res across the dose range of isoproterenol following vagal blockade (atropine). The slope and yintercept of this relationship were determined in each subject as described previously (19) and were used as an index ofleft ventricular contractile function taking into account the changes in EDD, as an index of preload and heart rate. The reproducibility of these measurements has been reported from our laboratory (25) .
Isoproterenol
Following acquisition of baseline echocardiographic data, each subject was given 1.0 mg of atropine intravenously. The rationale for the use of atropine was to minimize the confounding effect of vagal tone, because earlier studies suggested that during f3-adrenergic stimulation, it can have a significant negative inotropic effect (26, 27) . Therefore, we felt that atropine should be helpful to facilitate the interpretation of our findings. The reason for the selection of l-mg dose of atropine for all the subjects was that a reasonably good vagal blockade is generally attainable with this regimen without a significant risk of urinary retention in older men with prostatic hypertrophy. Furthermore, Poller and colleagues (28) have shown that age-related changes in several cardiovascular variables (HR, systolic blood pressure [SBP] , diastolic blood pressure [DBP] , and estimates of contractility) in response to cardiac muscarinic blockade were independent of doses of atropine ranging from 0.93 to 1.89 mg in individuals of similar age to the current study. Therefore, it appears that the effect of the differences in body weight on the effectiveness of vagal blockade would be small in our subjects.
Infusion of isoproterenol was commenced approximately 3 minutes after the administration of atropine at successive doses of 0.010,0.020,0.025, and 0.030 ug kg' min-I with the use of an infusion pump (Harvard Apparatus, Model 122: South Natick, MA) with simultaneous EeG and blood pressure (BP) monitoring. Each infusion stage lasted for 5 minutes. Repeat 2-D echocardiographic studies were performed 2 minutes following atropine administration and in the last 2 minutes of each stage of the isoproterenol infusion. BP was taken every 2 minutes with cuff sphygmomanometry simultaneously with echocardiographic recordings.
Statistics
The differences in variables between age groups and genders were compared with the use of a two-way analysis of variance. In response to vagal blockade, the effects of age and gender were analyzed by comparing the change in response for each variable from resting baseline to cholinergic muscarinic blockade with the use of a two-way analysis of variance. To assess the sensitivity of each variable to isoproterenol, the slopes of the linear portion of the dose-response curve for each subject across isoproterenol doses were analyzed with the use of a two- 
Subject Characteristics
The subjects' characteristics are listed in Table I . The men were heavier and taller compared to the women regardless of age (p < .05). Body surface area (BSA) was larger in the men than in the womenregardless of age (Table I ). There were both age and gender effectsforV0 2 max, with the young men having the highest and older women having the lowestV0 2 max (Table  I ). The lower V0 2 max observed in the older subjects was in part due to a slowermaximalheart rate (HRmax; Table I ). +Difference between age groups,p < .01. YW, young women (n =8); OW, older women (n =10);YM, young men (n =8); OM, older men (n =10).
ISP ( 
Cardiovascular Responses to 13-Adrener,gic Stimulation
We found that during the infusion of isoproterenol, all of the variablesexcept for SBP and DBP increasedrapidly in a linear fashion with the lower doses of isoproterenol. These variables reached a plateau during the final two infusion stages (i.e., 0.025 and 0.030 ug kgt.min'). It was, therefore, possibleto as-
Cardiovascular Responses Following Cardiac Muscarinic Receptor Blockade
Gender effects.-Baseline EDD and ESD were significantly largerin the men than in the women (Table I ). In contrast, EDD normalized for BSA was larger in the women (p < .05).
Baseline ESD normalizedfor BSA, the h/r ratio (Table I) Age effects.-Baseline EDD, ESD, left ventricularmass, the wall thickness-to-radius (h/r) ratio (Table I) 
Baseline Left Ventricular Size and Function Age X Gender Interaction Effects
The effectof age on FS in women was significantly (p < .05) different from the effect in men because baseline FS increased with age in the women, but did not in the men ( Figure I ). All other baseline measures did not exhibit any significantAge X Gender interaction effects. Gender effects.-The changes in EDD from baseline in response to vagal blockade were not different (p > .05) between the men (-0.3 ± 2.5 mm and 1.8 ± 5.0 mm, young and older, respectively) and women (-1.3 ± 1.7 mm and -0.8 ± 2.8 mm, young and older,respectively). There were also no statistically significantdifferences (p > .05) in the change in ESD from rest to vagal blockade between the men (1.1 ± 2.0 mm and 2.0 ± 5.1 mm, young and older,respectively) and women (-0.4 ± 1.7 mm and 0.9 ± 1.6 mm, young and older, respectively). The sess the sensitivity of each variable to isoproterenol by determining the slope of the linear portion of the dose-response curve for each subject.
Age effects.-EDD and ESD decreased in response to isoproterenol to similar extents in the young and older adults with no age-related effect ( Table 2 ). The young subjects exhibited a greater increase in FS with a steeper slope of the dose-response relationship (p < .01) than did the older subjects in response to isoproterenol, consistent with the age-associated diminished inotropic sensitivity to catecholamines (Table 2) . Left ventricular (fes decreased more in the young subjects (p < .01) compared to the older subjects ( Table 2 ). The FS-(fes relationship was linear for both older men and women (r = .916 ± .10 and .920 ± .095, respectively) and young men and women (r =.964 ± .06 and .984 ± .01, respectively). The average slope of the FS-(fesrelationships was steeper in the young than the older subjects but the difference was not statistically significant ( Figure 5) . Each group exhibited a progressive increase in HR in response to increasing doses of isoproterenol (Figure 2 ) but the differences in the chronotropic sensitivity were insignificant between young and older adults (Table 2 ). There was no age-related difference in the SBP (Figure 3 ) responses to isoproterenol. Diastolic blood pressure (Figure 3 ) decreased throughout the incremental doses of isoproterenol in all groups (p < .001). The young subjects, however, showed a greater decrease in the DBP response, i.e., a steeper slope of the dose-response curve, than did the older subjects (Table 2) .
Gender effects.-There were no gender-related differences in the EDD and ESD responses to isoproterenol ( Table 2 ). The observed gender-related differences in either FS or (fes responses to isoproterenol did not attain statistical significance ( Table 2 ). The slopes of the FS-(fesrelationship were not different between the genders ( Figure 5 ).
VOzmax correlated significantly with the inotropic responses to~-adrenergic stimulation, i.e., the slope of the FS-(fes rela- -Difference between age groups,p < .01. YW, young women (n =8); OW, older women (n =10);YM, young men (n =8); OM, older men (n =10). Sensitivity is reflected as the slope of the change during isoproterenol infusion. Data are means ± SD; *Difference between genders (p < .05); tdifference between age groups (p < .01); :j:interaction between age groups and genders (p < .05). DBP: diastolic blood pressure; EDD: left ventricular end-diastolic dimension; ESD: left ventricular end-systolic dimension; FS: fractional shortening; <T es : left ventricular end-systolic wall stress; HR.:heart rate; SBP: systolic blood pressure. Age X Gender interaction effects.-There were no Age X Gender interaction effects in the EDD, ESD, FS, or (Tes responses to isoproterenol (Table 2 ). However, we found significant Age X Gender interactions both for the slope (p =.006) and y-intercept (p < .00l) of the FS-(Tes relationship. The slope ( Figure 5 ) was steeper in the young men (-0.87 ± 0.29) compared to the older men (-0.41 ± 0.13) and in the young women (-0.55 ± 0.14) compared to the older women (-0.38 ± 0.13), showing a greater increase in FS in the younger than in older subjects for a given decrease in (Tes' In addition, young subjects showed a significant gender-related difference in the slope of the FS-(Tes relationship, with the young men showing a steeper slope than the young women ( Figure 5 ). In contrast, in the older groups the differences in the slope between the men and women were smaller and statistically insignificant ( Figure 5 ). Therefore, the men exhibited a greater age-related decline in inotropic responses to isoproterenol than did the women (p =.006, Figure   5 ). The y-intercept was significantly higher for the young men (76.41 ± 6.5%) compared to the older men (57.99 ± 8.1%), suggestive of an age-associated decline in the contractile response to isoproterenol in men. In contrast, the y-intercept was virtually identical between the young and older women (63.74 ± 4.9% and 63.07 ± 5.8%, respectively). The age-associated changes in the y-intercept of the FS-(Tes relationship were significantly (p < .001) different between men and women.
EFFECTS OF AGE AND GENDER ON LEFTVENTRICUIAR SYSTOliC PERFORMANCE
The effect of age on the HR responses to isoproterenol in men was significantly different from that in women. The slope of the HR response to isoproterenol was less steep (p < .05) in the older men compared to the young men, suggestive of an age-associated decline in the chronotropic sensitivity to isoproterenol in men (Table 2, Figure 2 ). In contrast, there was no age-associated difference in the slope of heart rate responses to isoproterenol between the young and older women (Table 2, Figure 2 ). There was no Age X Gender interaction effects in the SBP and DBP responses to isoproterenol. In order to examine the possible influence of different degrees of vagal blockade attributable to the dosage of atropine relative to body weight, we compared the cardiovascular responses between subgroups of subjects (three subjects per group) who received similar amounts of atropine relative to their body weight (young women = 14.5 ± 0.85 ug/kg, older women =14.8 ± 0.68Ilg/kg; young men =14.4 ± 1.53 ug/kg, older men = 14.0 ± 1.2 ug/kg; p =.62) in a separate analysis.
We found both age-and gender-related differences between the subgroups, with respect to FS and (Tes responses to isoproterenol, were similar to the entire groups, as outlined above. The HR response to vagal blockade was marginally different between the young women and young men (94.3 ± 7.7 bpm vs 78.7 ± 7.7 bpm, respectively;p =.07). In these subgroups who received similar doses of atropine relative to their body weight, the age-and gender-related differences in the contractile responses to isoproterenol were similar to those observed in the entire groups, as reflected in: (i) the slopes of the FS-(Tcs relationship (young women =-0.46 ± 0.03, older women =-0.28 ± 0.12; young men = -0.96 ± 0.17, older men = -0.43 ± 0.05; young men different from young women and older men, p = .02; young women not different from older women); and (ii) the intercepts of the FS-(Tes relationship (young women =60.5 ± 2.9%, older women = 60.2 ± 3.6%; young men =80.8 ± 7.1 %, older men =62.1 ± 3.4%; young men different from older men, p = .01; young women not different from older women).
DISCUSSION
The results of this study extends previous observations both in experimental animals (29, 30) and in humans (15, 17) , showing that aging results in diminished inotropic responses to (3-adrenergic stimulation, as evidenced by a decrease in the sensitivity of systolic shortening to isoproterenol and a less steep slope of the FS-(J"es relationship in the absence of changes in preload observed in the older adults. We also found that the younger men exhibited significantly greater positive inotropic responses to~-adrenergic stimulation than did the younger women. Therefore, our observations suggest that gender should be taken into consideration in assessment of the age-associated decline in the contractile response to~-adrenergic stimulation because this effect appears to be more pronounced in men than in women. Unlike previous studies (7, 28) , we used the FS-(J"es relationship because it is a reliable measure of LV contractile function, provided that preload and HR do not change significantly. In this study, the changes in EDD, used as an index of preload, in response to isoproterenol were small and not affected by either age or gender. The differences in chronotropic responses, which can affect the force-frequency relationship, may account for some of the differences in the LV contractile responses attributable to age and gender, because the increase in HR was smaller in the older men than in the young men.
One of the mechanisms underlying the age-related decrease in VOzmax which begins after the age of 25 (31) (32) (33) is the decline in maximal cardiac output (13) . Although cardiac output and stroke volume were not measured in the current study, the significant correlation that we found between the slope of the FS-(J"es relationship and VOzmax suggests that the ageassociated decrease in~-adrenoreceptor-mediated LVcontractile function can contribute to the lower maximal aerobic capacity in older adults by decreasing stroke volume, because changes in VOzmaxare influenced, in part, by alterations in cardiac output and stroke volume. The absence of a statistically significant larger LV mass in older subjects in this study may, in part, be due to a relatively low systolic blood pressure in these older men and women which could have prevented increased systolic loading.
Although studies in experimental animals (29, 30, 34) and humans (1, 7, 9) have documented the age-associated decreases in the chronotropic and inotropic responsiveness to~-adrenergic stimulation, only one has addressed the effect of gender (3) . Even in that study, only chronotropic responses to isoproterenol were reported (3). Ford and James (35) , using a larger dose of atropine, reported that the influence of age on the decrease in the chronotropic response to isoproterenol was lost with cardiac muscarinic receptor blockade (35) . Although we did not use a dose of atropine sufficient to induce total vagal blockade, we also found that the age-related decline in HR response to isoproterenol was small following atropine (p > .05) when the effect of gender was not taken into consideration.
Previous studies in older sedentary men reported an agerelated decrease in ejection fraction in response to dynamic exercise and isoproterenol (7, 10, 36) . Our findings are consistent with those published by Stratton and colleagues who used a slightly larger dose of isoproterenol without atropine (7) and suggest that the diminished ejection fraction response to exercise in older men reported previously (10, 36) may, at least in part, be mediated by the age-related decrease in the sensitivity to catecholamines because of the major role that the sympathetic nervous system plays in the circulatory adjustment during acute exercise. The new finding in this study is that gender can significantly modify the~-adrenergic-mediated increase in cardiac contractile function, with men showing a greater ageassociated decrease in LVcontractile function than women.
In vitro studies have reported a decrease in the contractile response to isoproterenol attributable to aging and the severity of heart disease (37, 38) . White and colleagues (39) assessed thẽ -receptors and postreceptor characteristics in explanted donor hearts of varying ages and found a substantial decrease in thẽ I-but not in the~z-receptor density with aging. The older hearts also exhibited a significant decrease in maximal tension in response to isoproterenol, which corresponded with the decrease in~I-receptor density. These findings provide further evidence that one of the potential mechanisms underlying the age-associated decline in cardiac function in response to environmental challenges is a reduction in sensitivity to catecholamines. Furthermore, our data suggest that aging can induce an attenuation of~z-mediated vasodilation, as reflected in a smaller decrease in DBP in older subjects.
The possible mechanism underlying the attenuation of the~ adrenergic-mediated cardiac responses in the older adults may involve changes in the myocardial adenosine levels and adenosine receptor AI function with advancing age. Adenosine has an antiadrenergic property with a direct negative chronotropic effect (34) and attenuation of~-adrenoreceptor-mediated contractile function (29, 34) . Aging induces the adenosine AI receptor-rnediated reductions in both postsynaptic~-adrenergic responses (40) and the release of norepinephrine from the adrenergic nerve terminals in the myocardium (41) . It is also associated with an increase in the interstitial concentration of adenosine in the myocardium (29) . Therefore, it is plausible to expect that the age-related decreases in the~-adrenergic responses and adenylyl cyclase activity are due to the increased extracellular adenosine level (29, 42) . However, others have presented evidence that suggest that the reductions in the~ adrenergic-mediated contractile reserve and adenylyl cyclase activity in senescence are associated with reduced capacity of adenosine to induce its antiadrenergic effect (34, 43) . It appears that the diminished~-adrenergic response with aging is mediated by a complex mechanism involving the age-associated reduction in coupling of adenosine Al receptors and their G proteins, and downregulation of the denosine AI receptors (34, 43) . In view of these observations, it would be plausible to postulate that our findings could be due to the gender-related differences in alterations in myocardial adenosine Al receptor function with advancing age. Further studies are obviously needed to explore this possibility.
The limitations of our study include a relatively small sample size because we attempted to exclude individuals with coronary artery disease and hypertension in order to evaluate the effects of aging per se. Another limitation is the dosage of atropine used in this study. Because the men were larger than the women regardless of age, the dosage of atropine relative to body weight was smaller in the men than in the women. Therefore, it is possible that the gender-related differences in our findings could have been due to the differences in the dosage of atropine. However, we believe that this is unlikely for the following reasons: (i) in the older subjects, the slopes of the FS-(J"es relationships were not significantly different between men and women even though the women received a larger dose of atropine which should induce a greater degree of vagal blockade and possibly a greater inotropic response to catecholamines because of the inhibitory effect of vagal tone on LV contractility (26,27,44); (ii) in the young subjects, the men who should have demonstrated a smaller increase in inotropic responses because of a smaller dose of atropine showed, in fact, a significantly greater inotropic response to isoproterenol, despite having a lesser vagal inhibition than women; (iii) there was no correlation between the increase in HR in response to atropine and body weight; and (iv) the gender-related differences in systolic contractile function were detectable even in those subjects who received similar doses of atropine per kilogram body weight. For these reasons, we believe it is unlikely that differences in the dose of atropine relative to the body weight can account for our findings.
In conclusion, the results of the present study provide evidence that older adults exhibit diminished inotropic responses to f3-adrenergic stimulation, which may account, in part, for the age-associated decrease in aerobic exercise capacity. In addition, it appears that gender plays a major role in the age-related decline in cardiac responses to catecholamines, with men showing a greater age-associated decrease in the inotropic and chronotropic responses to catecholamines than women.
